Bioinspired, Robust, and Absorbable Cellulose Nanofibrils/Chitosan Filament with Remarkable Cytocompatibility and Wound Healing Properties
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c08525 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Meiyan Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Biofuels, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China. Hauptthemen laut MEDLINE: Cellulose, Oxidized, Chitosan. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qingdao independent innovation major project, Shandong Energy Institute Research Foundation.
Themen: Wundversorgung
Abstract (Originalsprache)
Surgical threads are of great importance to prevent wound infection and accelerate tissue healing in surgical treatment. Cellulose nanofibrils (CNF) and chitosan (CS) are attracting increasing attention to be employed as biomedicine materials due to their nontoxicity, cytocompatibility, and biodegradability. However, a robust and absorbable cellulose-based surgical thread has not been explored. Therefore, in this work, a bioinspired CNF/CS composite thread containing 5% cationic polyacrylamide (CPAM) by the mass of CS was prepared, and the obtained CNF/CS-5C thread exhibited excellent mechanical properties and low swelling ratio in water due to the high cross-link degree. Especially, the tensile strength (1877 ± 107 MPa) of this thread was much higher than that of most reported CNF-based threads. Meanwhile, compared with commercial silk and Vicryl surgical threads, the CNF/CS-5C thread exhibited better in vitro cytocompatibility toward endothelial and fibroblast cells and lower inflammatory response in vivo to subcutaneous tissues of rats. In addition, the obtained thread could be regarded as a promising absorbable suture, which exhibited excellent wound healing performances in vivo. Therefore, the prepared absorbable thread will open a new window to prepare novel and advanced cellulose-based threads for medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Biofuels, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
- Laboratory of Theoretical and Computational Nanoscience, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
- Center for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
- Qingdao Hospital of Traditional Chinese Medicine (Municipal Hiser Hospital), Qingdao 266033, China.
- Shandong Energy Institute, Qingdao 266101, China.
- Qingdao New Energy Shandong Laboratory, Qingdao 266101, China.
ORCID-Profile: Meiyan Wu, Mei Li, Ruitao Cha, Bin Li
Förderung
- National Natural Science Foundation of China
- Qingdao independent innovation major project
- Shandong Energy Institute Research Foundation
Zitieren
APA
Wu, M., Zhang, P., Li, M., Xu, R., Zheng, X., Cui, Q., Cha, R., & Li, B. (2023). Bioinspired, Robust, and Absorbable Cellulose Nanofibrils/Chitosan Filament with Remarkable Cytocompatibility and Wound Healing Properties. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c08525
Vancouver
Wu M, Zhang P, Li M, Xu R, Zheng X, Cui Q, et al. Bioinspired, Robust, and Absorbable Cellulose Nanofibrils/Chitosan Filament with Remarkable Cytocompatibility and Wound Healing Properties. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c08525
BibTeX
@article{Wu2023,
author = {Wu, Meiyan and Zhang, Pai and Li, Mei and Xu, Rui and Zheng, Xin and Cui, Qiu and Cha, Ruitao and Li, Bin},
title = {Bioinspired, Robust, and Absorbable Cellulose Nanofibrils/Chitosan Filament with Remarkable Cytocompatibility and Wound Healing Properties},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c08525}
}
EUVIMED